Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry to publish all Phase III trials in peer-reviewed journals

This article was originally published in SRA

Executive Summary

The International Federation of Pharmaceutical Manufacturers and Associations and its members have committed to submitting the results of all industry-sponsored Phase III clinical trials for publication in scientific peer-reviewed journals. However, Germany’s health technology appraisal institute, IQWiG, said that the IFPMA’s bid to improve transparency does not go far enough to prevent publication bias.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS115380

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel